Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
Advanced therapy medicinal products (ATMPs) are a group of innovative and complex biological products for human use that comprises somatic cell therapy medicinal products, tissue engineered products, gene therapy medicinal products, and the so-called combined ATMPs that consist of one of the previou...
Saved in:
Main Authors: | Marina López-Paniagua (Author), Ana de la Mata (Author), Sara Galindo (Author), Francisco Blázquez (Author), Margarita Calonge (Author), Teresa Nieto-Miguel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency
by: Margarita Calonge, et al.
Published: (2021) -
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
by: Carolina Iglesias-Lopez, et al.
Published: (2019) -
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
by: Carolina Iglesias-Lopez, et al.
Published: (2020) -
Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges
Published: (2021) -
Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges
by: Yolanda Diebold, et al.
Published: (2021)